Digital endpoint research collaboration
We are actively seeking research partnerships to expand the evidence base for digital neuroscience assessment. Both the NeuroQuantix spiral analysis platform and FaceWise memory consolidation assessment are available for investigator-initiated studies, grant-funded research, and multi-site validation programs.
Our scoping review of 120 studies in Movement Disorders Clinical Practice identified the standardization gaps that our platforms address. Your research can help close them.
Research Opportunities
Two products, two distinct research programs. Both offer collaborative opportunities for academic investigators and research institutions.
NeuroQuantix Research Partnerships
Open for CollaborationAcademic movement disorder centers can partner with Cerebral Innovations on psychometric research using the NeuroQuantix platform under its standardized administration protocol: reliability, known-groups and concurrent validity against anchor scales, and sensitivity to change across movement disorder populations.
FaceWise Memory Consolidation Research
Open for CollaborationFaceWise implements the FNAME paradigm with AI-administered overnight delayed recall. Research opportunities span validation of consolidation-based endpoints across the Alzheimer continuum, sleep architecture studies, and decentralized trial methodology.
Research Partnerships
We partner with academic movement disorder centers on psychometric research using the NeuroQuantix platform under its standardized administration protocol. Sites with movement disorder patient populations and established research infrastructure are welcome to start a conversation.
What partners receive
Research questions
How we support your research
Platform Access
NeuroQuantix and FaceWise deployed for your study population with configured data exports, assessment protocols, and technical documentation.
Grant Support
Measurement methodology sections for grant applications, power analyses based on published effect sizes, and letters of support for funding agencies.
Study Design Consultation
Protocol design input on endpoint selection, assessment scheduling, sample size calculations, and digital endpoint integration with traditional scales.
Multi-Site Coordination
Standardized training materials, site qualification procedures, and centralized data quality monitoring across your research sites.
Co-Authorship
Collaborative research agreements with co-authorship opportunities. Your data, your questions, our measurement infrastructure.
Data and Analytics
CDISC-compatible data exports, kinematic feature extraction documentation, and statistical analysis support for your research team.
Frequently Asked Questions
How can researchers access NeuroQuantix or FaceWise for their studies?
Investigators running grant-funded or investigator-initiated studies can integrate NeuroQuantix or FaceWise as digital endpoints. We provide technical support, data export configuration, and co-authorship opportunities. Contact us to discuss your study design and how our platforms fit your research objectives.
What research partnerships does Cerebral Innovations offer for NeuroQuantix?
Academic movement disorder centers can partner on psychometric research using the NeuroQuantix platform under its standardized administration protocol, covering test-retest reliability, known-groups validity, concurrent validity against anchor scales, and sensitivity to change. Partnerships include the protocol, device configuration, training, co-authorship, and data-sharing agreements.
Can researchers use NeuroQuantix data in their publications?
Yes. Collaborative research agreements include co-authorship opportunities and data sharing arrangements. NeuroQuantix provides CDISC-compatible data exports that integrate with standard research data management workflows.
What grant support does Cerebral Innovations provide?
We provide measurement methodology sections for grant applications, technical documentation for IRB submissions, power analyses based on published effect sizes, and letters of support. Published data from our scoping review in Movement Disorders Clinical Practice strengthens the evidence base for grant reviewers.
Explore our platforms
NeuroQuantix Platform
Regulatory-grade digital endpoints from a brief drawing assessment. Full technical documentation.
FaceWise Assessment
AI-administered memory consolidation measurement for Alzheimer and cognitive decline research.
23 Assessed Conditions
Digital endpoints across ET, PD, dystonia, cerebellar ataxia, and 19 additional conditions.
Published Research
The scoping review and the published evidence for the metrics NeuroQuantix implements.
Compliance
21 CFR Part 11, HIPAA, GxP, and CDISC compliance documentation.
Ready to collaborate?
Tell us about your research program. Whether you are planning a research partnership, an investigator-initiated trial, or a grant application, we would welcome the conversation.
Start the Conversation